ATrial Fibrillation Registry and BIobank UlM

ATrial Fibrillation Registry and BIobank UlM - ATRIUM

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00013013

Enrollment

2000

Registered

2017-12-05

Start date

2017-12-05

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I48.0 I48.1 I48.3 I48.4 I48.9

Interventions

Group 1: Propspective observational study to collect baseline characteristics, procedural and outcome data as well as biomaterial samples to evaluate benefit of catheter ablation in patients with atr

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - documented paroxysmal or persistant atrial fibnrillation - written informed consent - age > 18 years

Exclusion criteria

Exclusion criteria: - permanent atrial fibrillation - LA > 60 mm - unable to consent

Design outcomes

Primary

Measure	Time frame
Recurrence of atrial fibrillation, Hospitalisation, Symptomatic Improvement (EHRA-Score)	—

Secondary

Measure	Time frame
Incidence of procedural complications such as pericardial tamponade, phrenic nerve palsy esophageal lesions or stroke.	—

Countries

Germany

Contacts

Public ContactSylvia Dippmann

Study Coordinator Arbeitsgruppe Elektrophysiologie - Universitätsklinikum Ulm - Innere Medizin II

sylvia.dippmann@uniklinik-ulm.de0731-500-45234

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 27, 2026